196 related articles for article (PubMed ID: 1319268)
1. In vivo occupation of mouse brain opioid receptors by endogenous enkephalins: blockade of enkephalin degrading enzymes by RB 101 inhibits [3H]diprenorphine binding.
Ruiz-Gayo M; Baamonde A; Turcaud S; Fournie-Zaluski MC; Roques BP
Brain Res; 1992 Feb; 571(2):306-12. PubMed ID: 1319268
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of delta-opioid receptors reduces the in vivo binding of the cholecystokinin (CCK)-B-selective agonist [3H]pBC 264: evidence for a physiological regulation of CCKergic systems by endogenous enkephalins.
Ruiz-Gayo M; Durieux C; Fournié-Zaluski MC; Roques BP
J Neurochem; 1992 Nov; 59(5):1805-11. PubMed ID: 1357099
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the enkephalin-metabolizing enzymes by the first systemically active mixed inhibitor prodrug RB 101 induces potent analgesic responses in mice and rats.
Noble F; Soleilhac JM; Soroca-Lucas E; Turcaud S; Fournie-Zaluski MC; Roques BP
J Pharmacol Exp Ther; 1992 Apr; 261(1):181-90. PubMed ID: 1560364
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of morphine withdrawal by the association of RB 101, an inhibitor of enkephalin catabolism, and the CCKB antagonist PD-134,308.
Maldonado R; Valverde O; Ducos B; Blommaert AG; Fournie-Zaluski MC; Roques BP
Br J Pharmacol; 1995 Mar; 114(5):1031-9. PubMed ID: 7780637
[TBL] [Abstract][Full Text] [Related]
5. Binding in vivo of selective mu and delta opioid receptor agonists: opioid receptor occupancy by endogenous enkephalins.
Meucci E; Delay-Goyet P; Roques BP; Zajac JM
Eur J Pharmacol; 1989 Nov; 171(2-3):167-78. PubMed ID: 2559856
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant-type effects of endogenous enkephalins protected by systemic RB 101 are mediated by opioid delta and dopamine D1 receptor stimulation.
Baamonde A; Daugé V; Ruiz-Gayo M; Fulga IG; Turcaud S; Fournié-Zaluski MC; Roques BP
Eur J Pharmacol; 1992 Jun; 216(2):157-66. PubMed ID: 1327810
[TBL] [Abstract][Full Text] [Related]
7. Involvement of delta-opioid receptors in the effects induced by endogenous enkephalins on learned helplessness model.
Tejedor-Real P; Micó JA; Smadja C; Maldonado R; Roques BP; Gilbert-Rahola J
Eur J Pharmacol; 1998 Jul; 354(1):1-7. PubMed ID: 9726624
[TBL] [Abstract][Full Text] [Related]
8. Paradoxical analgesia induced by low doses of naloxone is not potentiated by complete inhibition of enkephalin degradation.
Noble F; Fournié-Zaluski MC; Roques BP
Neuropharmacology; 1994 Jan; 33(1):135-40. PubMed ID: 7910383
[TBL] [Abstract][Full Text] [Related]
9. Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins.
Valverde O; Maldonado R; Fournie-Zaluski MC; Roques BP
J Pharmacol Exp Ther; 1994 Jul; 270(1):77-88. PubMed ID: 8035345
[TBL] [Abstract][Full Text] [Related]
10. Possible role of distinct morphine and enkephalin receptors in mediating actins of benzomorphan drugs (putative kappa and sigma agonists).
Chang KJ; Hazum E; Cuatrecasas P
Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4469-73. PubMed ID: 6254028
[TBL] [Abstract][Full Text] [Related]
11. Role of endogenous cholecystokinin in the facilitation of mu-mediated antinociception by delta-opioid agonists.
Noble F; Smadja C; Roques BP
J Pharmacol Exp Ther; 1994 Dec; 271(3):1127-34. PubMed ID: 7996417
[TBL] [Abstract][Full Text] [Related]
12. Analgesic responses elicited by endogenous enkephalins (protected by mixed peptidase inhibitors) in a variety of morphine-sensitive noxious tests.
Schmidt C; Peyroux J; Noble F; Fournié-Zaluski MC; Roques BP
Eur J Pharmacol; 1991 Jan; 192(2):253-62. PubMed ID: 2032557
[TBL] [Abstract][Full Text] [Related]
13. Differences in physical dependence induced by selective mu or delta opioid agonists and by endogenous enkephalins protected by peptidase inhibitors.
Maldonado R; Feger J; Fournié-Zaluski MC; Roques BP
Brain Res; 1990 Jun; 520(1-2):247-54. PubMed ID: 2169953
[TBL] [Abstract][Full Text] [Related]
14. Opposite role of CCKA and CCKB receptors in the modulation of endogenous enkephalin antidepressant-like effects.
Smadja C; Maldonado R; Turcaud S; Fournie-Zaluski MC; Roques BP
Psychopharmacology (Berl); 1995 Aug; 120(4):400-8. PubMed ID: 8539320
[TBL] [Abstract][Full Text] [Related]
15. Repeated systemic administration of the mixed inhibitor of enkephalin-degrading enzymes, RB101, does not induce either antinociceptive tolerance or cross-tolerance with morphine.
Noble F; Turcaud S; Fournié-Zaluski MC; Roques BP
Eur J Pharmacol; 1992 Nov; 223(1):83-9. PubMed ID: 1478260
[TBL] [Abstract][Full Text] [Related]
16. Novel opiate binding sites selective for benzomorphan drugs.
Chang KJ; Hazum E; Cuatrecasas P
Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4141-5. PubMed ID: 6270660
[TBL] [Abstract][Full Text] [Related]
17. Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect.
Valverde O; Noble F; Beslot F; Daugé V; Fournié-Zaluski MC; Roques BP
Eur J Neurosci; 2001 May; 13(9):1816-24. PubMed ID: 11359533
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of the effects of a complete inhibitor of enkephalin-catabolizing enzymes, RB 101, by a cholecystokinin-B receptor antagonist in diabetic rats.
Coudoré-Civiale MA; Méen M; Fournié-Zaluski MC; Boucher M; Roques BP; Eschalier A
Br J Pharmacol; 2001 May; 133(1):179-85. PubMed ID: 11325808
[TBL] [Abstract][Full Text] [Related]
19. Pain-suppressive effects on various nociceptive stimuli (thermal, chemical, electrical and inflammatory) of the first orally active enkephalin-metabolizing enzyme inhibitor RB 120.
Noble F; Smadja C; Valverde O; Maldonado R; Coric P; Turcaud S; Fournié-Zaluski MC; Roques BP
Pain; 1997 Dec; 73(3):383-391. PubMed ID: 9469529
[TBL] [Abstract][Full Text] [Related]
20. Modulation of opioid antinociception by CCK at the supraspinal level: evidence of regulatory mechanisms between CCK and enkephalin systems in the control of pain.
Noble F; Derrien M; Roques BP
Br J Pharmacol; 1993 Aug; 109(4):1064-70. PubMed ID: 8401918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
